Literature DB >> 32724450

Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer.

Chunying Yu1, Ting Dou1, Yun Liu1, Ruirong Liu1.   

Abstract

Clinical application value was investigated of transvaginal color Doppler ultrasound (TV-CDS) combined with serum tumor markers carbohydrate antigen 125 (CA125), vascular endothelial growth factor (VEGF) and osteopontin (OPN) in the diagnosis of ovarian cancer (OC). One hundred and six patients with OC [malignant tumor group (MTG)] and fifty patients with benign ovarian diseases [benign control group (BCG)] were selected. Both groups of patients underwent TV-CDS examination. The lesion morphology and internal structure were observed, and the tumor blood flow signal, resistance index (RI) and pulsability index (PI) under ultrasound were determined. Serum CA125 was detected by electrochemiluminescence, and VEGF and OPN levels were detected by enzyme-linked immunosorbent assay. The incidence of irregular lesion morphology, unclear boundary, uneven internal echo, microcalcification and side-acoustic images in OC group (OCG) was significantly higher than that in BCG (P<0.01). As for blood flow grading, most patients in the MTG were in grade II and III, while most patients in the BCG were in grade 0. Compared with BCG, the flow RI and PI in the OCG were significantly reduced (P<0.01). The levels of serum CA125, VEGF and OPN in OCG were significantly higher than those in BCG. The expression levels of serum CA125, VEGF and OPN in OC patients with clinical high stage (stage III and IV), poorly differentiated, ascites, recurrence and metastasis were significantly higher than those in patients with clinical low stage (stage I and II), well differentiated, no ascites and no recurrence and metastasis (P<0.05). With the disappearance of the tumor or the decrease of tumor load, the serum marker levels after treatment were significantly lower than that before treatment (P<0.05). The sensitivity and accuracy of the combined examination in the diagnosis of OC were obviously improved compared with the single and partial combined examinations (P<0.05). In conclusion, combined examination can significantly improve the sensitivity and accuracy of OC, which is conducive to early diagnosis and clinical intervention of OC.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  color doppler ultrasound; combined examination; ovarian cancer; serology; transvaginal; tumor markers

Year:  2020        PMID: 32724450      PMCID: PMC7377109          DOI: 10.3892/ol.2020.11705

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Osteopontin-c splicing isoform contributes to ovarian cancer progression.

Authors:  Tatiana M Tilli; Vanessa Ferreira Franco; Bruno Kaufmann Robbs; João Luiz Mendes Wanderley; Fabrício Ribeiro de Azevedo da Silva; Kivvi Duarte de Mello; João P B Viola; Georg F Weber; Etel R Gimba
Journal:  Mol Cancer Res       Date:  2011-01-24       Impact factor: 5.852

2.  Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.

Authors:  Michèl Schummer; Charles Drescher; Robin Forrest; Shirley Gough; Jason Thorpe; Ingegerd Hellström; Karl Erik Hellström; Nicole Urban
Journal:  Gynecol Oncol       Date:  2011-12-07       Impact factor: 5.482

Review 3.  Ovarian cancer: screening and future directions.

Authors:  Keshav Kumar Gupta; Vinay Kumar Gupta; Robert Wendel Naumann
Journal:  Int J Gynecol Cancer       Date:  2019-01       Impact factor: 3.437

4.  Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer.

Authors:  Guanhua Rao; Hongyi Wang; Baowei Li; Li Huang; Danfeng Xue; Xiaohui Wang; Haijing Jin; Jun Wang; Yushan Zhu; Youyong Lu; Lei Du; Quan Chen
Journal:  Clin Cancer Res       Date:  2012-12-18       Impact factor: 12.531

5.  Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.

Authors:  Li Li; Limei Wang; Wei Zhang; Bujian Tang; Jieqing Zhang; Honglin Song; Desheng Yao; Yong Tang; Xinqiu Chen; Zhihua Yang; Gangduo Wang; Xiping Li; Jinshun Zhao; Hong Ding; Eddie Reed; Qingdi Q Li
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

6.  Color Doppler ultrasonography for prediction of malignant ovarian tumors.

Authors:  Mongkol Benjapibal; Prasert Sunsaneevitayakul; Dittakarn Boriboonhirunsarn; Anuwat Sutanthavibul; Manoch Chakorngowit
Journal:  J Med Assoc Thai       Date:  2002-06

7.  The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler.

Authors:  Asim Kurjak; Sanja Kupesic; Vladimir Sparac; Matija Prka; Ivanka Bekavac
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

8.  Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects.

Authors:  Hiromichi Wada; Shuichi Ura; Shuji Kitaoka; Noriko Satoh-Asahara; Takahiro Horie; Koh Ono; Tomohide Takaya; Rieko Takanabe-Mori; Masaharu Akao; Mitsuru Abe; Tatsuya Morimoto; Toshinori Murayama; Masayuki Yokode; Masatoshi Fujita; Akira Shimatsu; Koji Hasegawa
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

9.  The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer.

Authors:  Zhi-Jun Yang; Bing-Bing Zhao; Li Li
Journal:  J Ovarian Res       Date:  2016-09-15       Impact factor: 4.234

10.  Correlation between ovarian neoplasm and serum levels of osteopontin: a meta-analysis.

Authors:  Yue-Dong Wang; He Chen; Hui-Qiag Liu; Min Hao
Journal:  Tumour Biol       Date:  2014-09-06
View more
  5 in total

1.  Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model.

Authors:  Haixia Wang; Pingping Liu; Hai Xu; Hongmei Dai
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Effects of carboplatin combined with paclitaxel-based intraperitoneal hyperthermic perfusion chemotherapy on serum levels of HE4 and DJ-1 in patients with advanced recurrent ovarian cancer.

Authors:  Xianhui Su; Xuewen Sun; Yanhui Kang; Yuna Dai
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

Review 3.  Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.

Authors:  Sima Chaudhari; Satyajit Dey Pereira; Meshach Asare-Warehene; Ritam Naha; Shama Prasada Kabekkodu; Benjamin K Tsang; Kapaettu Satyamoorthy
Journal:  J Ovarian Res       Date:  2021-02-25       Impact factor: 4.234

4.  Diagnostic Value of Serum Markers Combined with TVCDS in Ovarian Cancer Patients Treated with Bushen Yiqi Quyu Prescription.

Authors:  Wei Qin; Fengmin Jiang; Tao Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-13       Impact factor: 2.629

5.  The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis.

Authors:  SiJin Li; Ping Liu; XiaoTeng Feng; YiRu Wang; Min Du; JiaRou Wang
Journal:  PLoS One       Date:  2022-05-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.